Table 2 Number of Donations by COVID-19 Convalescent Plasma Donors and Clinical Characteristics of Their Infections
From: Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors
CCDs (n = 162) | |
|---|---|
Donations (n, %, days post symptom onset) | 270 (100), 116.3 ± 43.9 |
Single | 93 (34.4), 108.8 ± 44.8 |
Twice | 46 (34.8), 120 ± 40.9 |
Thrice | 12 (14.4), 126.6 ± 46.6 |
Four | 6 (8.8), 113.2 ± 42.1 |
Five | 5 (7.4), 121.7 ± 48.6 |
Disease severity (n, %) | |
Mild | 148 (91.4) |
Moderate | 10 (6.1) |
Severe | 3 (1.8) |
Asymptomatic | 1 (0.6) |
Blood Group (n, %) | |
O | 67 (41.1) |
A | 57 (36.8) |
B | 22 (13.4) |
AB | 11 (6.7) |
Unknown | 5 (3.0) |
Antibodies | |
Total Anti-SARS-CoV-2 | 392.6 ± 300.2 |
IgG Anti-SARS-CoV-2 | 10.66 ± 7.59 |
Neutralizing Antibody (n, %) | 270 (100) |
< 1:40 | 9 (3.3) |
1:40 | 83 (30.7) |
1:80 | 65 (24.0) |
1:160 | 28 (10.3) |
1:320 | 9 (3.3) |
1:640 | 2 (0.7) |
None | 72 (26.6) |
Not Tested | 1 (0.3) |
Pending | 1 (0.3) |